|
Q1 FY2027
As of Aug 29, 2026
|
Q4 FY2026
As of May 30, 2026
|
Q3 FY2026
As of Feb 28, 2026
|
Q2 FY2026
As of Nov 29, 2025
|
Q1 FY2026
As of Aug 30, 2025
|
Q4 FY2025
As of May 31, 2025
|
Q3 FY2025
As of Feb 22, 2025
|
Q2 FY2025
As of Nov 23, 2024
|
Q1 FY2025
As of Aug 24, 2024
|
Q4 FY2024
As of May 25, 2024
|
Q3 FY2024
As of Feb 24, 2024
|
Q2 FY2024
As of Nov 25, 2023
|
Q1 FY2024
As of Aug 26, 2023
|
Q4 FY2023
As of May 27, 2023
|
Q3 FY2023
As of Feb 25, 2023
|
Q2 FY2023
As of Nov 26, 2022
|
Q1 FY2023
As of Aug 27, 2022
|
Q4 FY2022
As of May 28, 2022
|
Q3 FY2022
As of Feb 26, 2022
|
Q2 FY2022
As of Nov 27, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade accounts receivable, net of allowances of $1,380 and $1,339 as of August 29, 2026 and May 30, 2026, respectively | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and other accrued expenses | ||||||||||||||||||||
| Accrued salaries and related obligations | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Contingent consideration liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 5,000 shares authorized; zero shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value, 70,000 shares authorized; 38,557 and 38,295 shares issued, and 34,702 and 34,440 shares outstanding as of August 29, 2026 and May 30, 2026, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock at cost, 2,386 and 2,070 shares as of February 24, 2024 and May 27, 2023, respectively | ||||||||||||||||||||
| Treasury stock at cost, 3,855 and 3,855 shares as of August 29, 2026 and May 30, 2026, respectively | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
